NASDAQ:CRSP
CRISPR Therapeutics Stock News
$56.22
+0.550 (+0.99%)
At Close: May 17, 2024
A Comprehensive Guide to Genomic ETFs
05:17pm, Friday, 09'th Jul 2021
Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.
Will CRISPR Stock Rebound After A 10% Fall In A Week?
07:30am, Friday, 09'th Jul 2021
The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year bef
Crispr Therapeutics: Get Ready To Bail Out
09:00am, Monday, 05'th Jul 2021
The company is lagging behind established pharmaceutical companies. Other cheaper alternatives are on the way.
Here's What Drove Gene Editing Stocks Higher This Week
12:48pm, Friday, 02'nd Jul 2021
The most exciting clinical trial data in the medical community has huge implications for Intellia, and its peers.
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century
07:30am, Thursday, 01'st Jul 2021
Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy. The post The Top 7 Gene-Editing Stocks to Buy for the Biggest S
Gene Editing Stocks: Why EDIT, CRSP, NTLA Stocks Continue to Soar
02:12pm, Wednesday, 30'th Jun 2021
Today, gene editing stocks are soaring amid increasingly bullish sentiment in this sector following strong results from Intellia. The post Gene Editing Stocks: Why EDIT, CRSP, NTLA Stocks Continue to
Genomics ETFs Surge on a Major Breakthrough in CRISPR Study
02:04pm, Wednesday, 30'th Jun 2021
The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.
Meme Stocks Get Off to a Strong Start As Nasdaq Hits New Highs
10:59am, Monday, 28'th Jun 2021
The broad markets saw a somewhat mixed start to the week with the Dow Jones Industrial Average lagging both the S&P 500 and Nasdaq.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
10:36am, Monday, 28'th Jun 2021
So what will the stock market do today? All eyes are on gene-editing stocks like NTLA and on recovering crypto prices.
CRSP Stock Price Increases Over 10% Pre-Market: Why It Happened
08:55am, Monday, 28'th Jun 2021
The stock price of Crispr Therapeutics AG (NASDAQ: CRSP) increased by over 10% pre-market. This is why it happened.
New All-Time Highs in Nasdaq and S&P 500: What This Means For Meme Stocks
10:10am, Thursday, 24'th Jun 2021
The broad markets saw another push higher on Thursday with the S&P 500 and Nasdaq setting new all-time highs in the session.
High-Growth Stocks Come Back Into Investors' Favor
08:18pm, Wednesday, 23'rd Jun 2021
The short-term bottom for next-generation enterprises is in, and high multiple stocks are returning to investors' favor.
Monday's Crypto Breakdown and Meme Stock Meltdown
10:20am, Monday, 21'st Jun 2021
The Dow climbed over 1% early on Monday as a result of a strong push from industrial stocks.
CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know
06:48pm, Friday, 18'th Jun 2021
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $127.83, marking a +0.44% move from the previous day.
Why demand for CRISPR gene editing is increasing
02:48pm, Thursday, 17'th Jun 2021
CNBC's Meg Tirrell discusses CRISPR gene editing with one of its inventors, Jennifer Doudna, UC Berkeley biochemist.
